Bone marrow cells improve cardiac function in heart attack patients

03/30/2009 | Yahoo!

Patients who received higher doses of AMR-001 -- bone marrow stem cells that had started to transform into endothelial cells -- after suffering a heart attack showed better blood circulation in the heart than those who got lower doses of cells or took drugs alone, according to a study by biotech firm Amorcyte. The company plans to conduct a larger clinical trial of AMR-001, said Dr. Andrew Pecora, chairman of the Amorcyte board.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC